Santa Monica, CA, United States of America

Stephan R Targan

USPTO Granted Patents = 50 

 

Average Co-Inventor Count = 3.5

ph-index = 14

Forward Citations = 497(Granted Patents)

Forward Citations (Not Self Cited) = 272(Oct 12, 2025)


Location History:

  • Los Angeles, CA (US) (1997 - 2005)
  • Santa Monica, CA (US) (1999 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
50 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Stephan R. Targan**

Introduction

Stephan R. Targan is a prominent innovator based in Santa Monica, California, known for his groundbreaking work in the field of inflammatory bowel disease (IBD). With an impressive portfolio of 47 patents, Targan's inventions focus on diagnosing and treating conditions like Crohn's disease and ulcerative colitis, contributing significantly to advancements in medical science.

Latest Patents

Among Targan's latest patents, one noteworthy invention provides methods for the diagnosis and treatment of inflammatory bowel disease. This invention offers techniques for predicting susceptibility to IBD and its progression by identifying specific genetic variants, such as NOD2, TLR8, TLR2, CARD8, CARD15, and JAK3. Another embodiment outlines methods for evaluating the presence of certain anti-bacterial antibodies in individuals to aid in the diagnosis and management of IBD.

In addition, Targan's research delves into determining responsiveness to anti-TNFα therapy in individuals diagnosed with IBD. By assessing various risk factors, including genetic and serological markers, this work aims to optimize treatment strategies for better patient outcomes.

Career Highlights

Targan has held significant positions at esteemed institutions such as Cedars-Sinai Medical Center and the University of California. His experience in leading research initiatives has fostered innovative advancements in understanding and treating IBD, making him a key figure in the medical research community.

Collaborations

Throughout his career, Targan has collaborated with notable professionals in the field, including Jerome I. Rotter and Kent D. Taylor. These partnerships have further enriched his research, allowing for a comprehensive approach to tackling the complexities of inflammatory bowel disease.

Conclusion

Stephan R. Targan's dedicated efforts in the realm of medical innovation have made a lasting impact on the diagnosis and treatment of inflammatory bowel disease. His extensive patent portfolio not only reflects his inventiveness but also signifies a commitment to improving patient care through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…